Picture of Cohance Lifesciences logo

COHANCE — Cohance Lifesciences News Story

0.000.00%
in flag iconLast trade - 00:00
HealthcareAdventurousMid CapFalling Star

India's Cohance slips as quarterly profit slumps; Jefferies cuts rating, PT

** Shares of India's Cohance Lifesciences COHA.NS fall as much as ~8.6% to 443 rupees

** The pharmaceutical company's quarterly profit down ~83.8% y/y to 195.5 million rupees ($2.04 million), pressured by lower sales, higher costs

** Revenue from operations down ~26.3% y/y

** Jefferies downgrades COHA rating to "underperform" from "hold", cuts PT by 40 rupees to 300 rupees

** Trims FY27-FY28 EPS estimates by 14%-17%, citing near-term growth challenges and margin pressure from higher costs

** YTD, COHA stock down ~13%

($1 = 95.6300 Indian rupees)

 (Reporting by Bipasha Dey in Bengaluru)

 ((Bipasha.Dey@thomsonreuters.com;))

Recent news on Cohance Lifesciences

See all news